COVID-19 Spain pulse oximeters donation
Boehringer Ingelheim Spain has contributed to the COVIDALARM project by financing the purchase of 200 intelligent pulse oximeters. Learn more here.
Search
Boosting performance with an inclusive performance culture
Inclusive leaders and an inclusive organisation allow diversity to flourish. Diversity is the mix. Inclusion is making the mix work. Learn more here.
The Angels Initiative
The Angels Initiative is a unique healthcare initiative to improve acute care for people who have just suffered a stroke. Click here to learn more.
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management. Click here to find out more information.
Our-position
12 years ago, several leading German companies including Boehringer Ingelheim came together to launch Afrika Kommt! Learn more about it here.
Angels Initiative in South Africa
Dr Stacey Rossouw explains how the Angels initiative is making a difference in South Africa and optimising stroke care. Click here to learn more.
Benefits of Pradaxa®
Here you can find a discussion of the benefits offered by Pradaxa® for stroke prevention in patients with atrial fibrillation. Click here to learn more.
Patient-Discussion-Guide.pdf
Patient-Discussion-Guide.pdf
Harold_and_Dorothy_Patient_Discussion_Guide_Factsheet_0.pdf
Payments to patient organisations 2019
Harold_and_Dorothy_Patient_Discussion_Guide_Factsheet_0.pdf
Innovation Needs Transparency
At Boehringer Ingelheim, we prioritise the establishment and maintenance of public trust. Transparency is therefore a key pillar of our corporate culture.
COVID-19 Mentally strengthened through the Corona crisis
Our individual employee consultation offers employees several support options to manage the pandemic with strengthened mental health. Learn more.
Trust Through Transparency
Trust is a precious thing, and building trust takes hard work—especially in the healthcare sector. Click here to learn more about how we build trust.
COVID-19 Supply Chain and Production
Supplying patients and customers with their medicines is our highest priority. Learn about COVID-19's impact on our supply chain and production here.
10 tips cat friendly veterinary clinics
Here we take a look at 10 simple steps you can take to make feline patients feel at ease at your practice. Click here to find out more information.
Jardiance® (empagliflozin) now approved in India for treatment of chronic kidney disease
Jardiance® (empagliflozin) now approved in India
Production Insights
Boehringer Ingelheim makes an important contribution to the reliable and sustainable supply of pharmaceuticals. Click here to learn and find out more.
Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state
Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state
Our Partnering Culture
We embrace the power of partnerships and alliances to find even more breakthrough therapies that change lives. Find out more about our partnering culture.
COVID-19 Southeast Asia Support of Healtvare Community
Learn more about what Boehringer Ingelheim is doing to assist health workers in managing the pandemic in Southeast Asia. Click here to find out more.
COVID-19 Global Access Commitment with Gates Foundation
Boehringer Ingelheim commits to provide global access to COVID-19 therapeutics by signing a communiqué with the Bill & Melinda Gates Foundation.
Collaboration to fight NCDs
70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed.
Boehringer Ingelheim India enters into second collaboration with SIIC IIT Kanpur to support healthcare innovation
Boehringer Ingelheim India enters into second collaboration with SIIC IIT Kanpur to support healthcare innovation